{
    "clinical_study": {
        "@rank": "58906", 
        "arm_group": {
            "arm_group_label": "Muscle derived stem cell", 
            "arm_group_type": "Experimental", 
            "description": "Paraurethral injection of muscle derived stem cell in patients with stress urine incontinency."
        }, 
        "brief_summary": {
            "textblock": "This study was designed to provide confirmation of efficacy of muscle derived stem cells\n      (MDCs) for the treatment of SUI in women."
        }, 
        "brief_title": "Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Stress Urine Incontinency", 
        "detailed_description": {
            "textblock": "The investigators will be assessed the 12-month potential efficacy of autologous muscle\n      derived cells as therapy for stress urinary incontinence. A total of 20 women in whom stress\n      urinary incontinence had not improved underwent intra-sphincter injection of low doses\n      50\u00d7106 of autologous muscle derived cells, which will be derived from biopsies of their\n      deltoid muscle. Assessments will be made at 1, 3, 6 and 12 months after cell injection.\n      Changes in stress urinary incontinence severity were evaluated by pad test, diary of\n      incontinence episodes and quality of life surveys."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female\n\n          -  Stress Urinary Incontinence symptoms\n\n          -  Urodynamic stress incontinence confirmed with multichannel urodynamic testing\n\n          -  positive cough stress test\n\n          -  urgency score < stress score\n\n          -  Patient's age between 40 - 65 years\n\n          -  Desire to surgical correction of stress urinary incontinence or inadequate response\n             to conservative treatment of SUI\n\n        Exclusion Criteria:\n\n          -  Post-void residual volume >100cc\n\n          -  Detrusor overactivity on preoperative multichannel urodynamic testing\n\n          -  History of previous synthetic, biologic or fascial sub-urethral sling or any other\n             surgery on external genitalia, bladder neck, bladder or urethra\n\n          -  Desires future childbearing\n\n          -  Chronic inguinal or vulvar abscess or history of Hidradenitis Suppurative\n\n          -  History of bleeding diathesis or current anti-coagulation therapy\n\n          -  Inguinal lymphadenopathy or inguinal/vulvar mass\n\n          -  Current genitourinary fistula or urethral diverticulum\n\n          -  Current sever cystocele or rectocele\n\n          -  Active urinary infection\n\n          -  Non-treated urge incontinency or any significant voiding dysfunction\n\n          -  Neuromuscular disorders\n\n          -  Uncontrolled Diabetes\n\n          -  Reversible cause of incontinence (i.e. drug effect)\n\n          -  Contraindications for surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 2, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02156934", 
            "org_study_id": "Royan-Kidney-002"
        }, 
        "intervention": {
            "arm_group_label": "Muscle derived stem cell", 
            "description": "Paraurethral injection of muscle derived stem cell in patients with stress urine incontinency.", 
            "intervention_name": "paraurethral injection", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "autologous stress urinary incontinence muscle derived cells", 
        "lastchanged_date": "June 3, 2014", 
        "link": {
            "url": "http://Royaninstitute.org"
        }, 
        "location": {
            "contact": {
                "email": "nasser.aghdami@royaninstitute.org", 
                "last_name": "Nasser Aghdami, MD,PhD", 
                "phone": "(+98)212356000", 
                "phone_ext": "516"
            }, 
            "contact_backup": {
                "email": "Leara91@gmail.com", 
                "last_name": "Leila Arab, MD", 
                "phone": "(+98)23562000", 
                "phone_ext": "414"
            }, 
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Royan Institute"
            }, 
            "investigator": {
                "last_name": "Reza Moghadasali, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation the Effect of Autologous Muscle Derived Stem Cells Injection Into the Paraurethral Tissues for Treatment of Stress Urinary Incontinency,The Randomized Clinical Trial Phase II", 
        "overall_contact": {
            "email": "nasser.aghdami@royaninstitute.org", 
            "last_name": "Nasser Aghdami, MD,PhD", 
            "phone": "(+98)23562000", 
            "phone_ext": "516"
        }, 
        "overall_contact_backup": {
            "email": "Leara91@gmail.com", 
            "last_name": "Leila Arab, MD", 
            "phone": "(+98)23562000", 
            "phone_ext": "414"
        }, 
        "overall_official": [
            {
                "affiliation": "Head of Royan Institute", 
                "last_name": "Hamid Gourabi, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Head of Department of Regenerative Medicine & Cell therapy center of Royan Institute", 
                "last_name": "Nasser Aghdami, MD,PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences", 
                "last_name": "Farzaneh Sharifiaghdas, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences", 
                "last_name": "Farshad Zoharabi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology", 
                "last_name": "Reza Moghadasali, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Iran: Ethics Committee", 
                "Iran: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluation the 24hr voiding diary reduction by patient questionnaire 2hr pad test and cystourethroscopy and urodynamic.", 
            "measure": "24hr voiding diary reduction", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02156934"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluation the increasing of incontinence quality of life (I-Qol) by questionnaire form.", 
            "measure": "incontinence quality of life (I-Qol)", 
            "safety_issue": "Yes", 
            "time_frame": "1month"
        }, 
        "source": "Royan Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Royan Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}